Estrogen and Cardiovascular Health: Nutritional Implications for - - PowerPoint PPT Presentation

estrogen and cardiovascular health nutritional
SMART_READER_LITE
LIVE PREVIEW

Estrogen and Cardiovascular Health: Nutritional Implications for - - PowerPoint PPT Presentation

Estrogen and Cardiovascular Health: Nutritional Implications for Peri- and Post-Menopausal Women* Dr. Felice Gersh, M.D. Dr. Gersh has been retained as a medical consultant in advising Pure Encapsulations. *These statements have not been


slide-1
SLIDE 1

Estrogen and Cardiovascular Health: Nutritional Implications for Peri- and Post-Menopausal Women*

  • Dr. Felice Gersh, M.D.†

† Dr. Gersh has been retained as a medical consultant in advising Pure Encapsulations.

*These statements have not been evaluated by the Food & Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

slide-2
SLIDE 2

Felice Gersh, M.D. I am a paid medical advisor for Pure Encapsulations. I have no other conflicts of interest to disclose. The Company assumes no liability for presenter’s information, whether conveyed verbally

  • r in these materials. All presentations represent the opinions of the presenter and do not

represent the position or the opinion of the Company. Reference by the presenter to any specific product, process or service by trade name, trademark, or manufacturer does not constitute or imply endorsement or recommendation by the Company. Seminars, teleconferences and webinars such as this are for educational purposes only and are intended for licensed health care practitioners. These therapies are not substitutions for standard medical care. Practitioners are solely responsible for the care and treatment provided to their own patients.

Speaker Disclosure

slide-3
SLIDE 3

Learning Objectives

1. Understand the biochemical role of estrogen in maintaining vascular function. 2. Recognize the impact of menopause on cardiovascular health. 3. Learn which tests, diets, lifestyle changes and supplements can support the cardiovascular system in peri- and post-menopausal women.*

*These statements have not been evaluated by the Food & Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

slide-4
SLIDE 4

The Significance of Cardiovascular Health

Center for Disease Control and Prevention.

Coronary artery disease (CAD) is the number one cause of death in women (and men) in the world More than all forms of cancer, diabetes, Alzheimer’s & pneumonia

slide-5
SLIDE 5

Cardiovascular Health is often Overlooked in Women

  • Historically, women have been underrepresented in cardiovascular

research.

  • Most women believe CAD is a “man’s disease”
  • When women are diagnosed, outcomes are usually worse-- Women are

typically treated more conservatively

  • Women have the benefits of estrogen (but that doesn’t make them

invincible) and those benefits are substantially reduced with the onset of menopause

Ramachandran H, Wu V, Kowitlawakul Y, Wang W. Heart & Lung. 2016; 45: 173-185

slide-6
SLIDE 6

The Role of Estrogen

Estrogen:

  • Influences gene expression
  • Also activates non-genomic pathway
  • Modifies the physiology,

electrophysiology and pathophysiology

  • f the heart

Skin Bladder/Prostate Central nervous system Liver Endothelium Breast Lung Mitochondria Ovary/Uterus Bone/Joints/Immune Cells Gastrointestinal Tract Muscles Smooth muscle cells

slide-7
SLIDE 7

Estrogen-Regulated Cardiovascular-related Genes

Vasodilation and vasoconstriction

  • Prostacyclin cyclooxygenase
  • Prostacyclin synthase
  • Endothelial NO synthase
  • Renin and angiotensin
  • Endothelin-1

Lipid Metabolism

  • Lipoprotein lipase
  • Apolipoproteins
  • Leptin

Immune activity

  • Vascular-cell adhesion molecule
  • Cytokines (IL1, IL6, TNFα)
  • Cytokine receptors

Coagulation

  • Fibrinogen
  • Coagulation factors
  • Protein S

Angiogenesis

  • Matrix metalloproteinase
  • Vascular endothelial growth factor

Saltiki, K and Alevizaki M.. Hormones. 2007; 6(1): 9- 24

Non-Genomic Effects

  • Fast-acting actions such as NO

facilitated vasodilation

slide-8
SLIDE 8

Vasodilation: Endothelial Nitric Oxide Synthase (eNOS)

Estrogen upregulates the expression of eNOS, which synthesizes NO In the endothelium, NO:

  • Is essential for vasodilation
  • Decreases leukocyte recruitment
  • Functions as an antioxidant

Nitric oxide levels are associated with:

  • Endothelial function
  • Vascular health

Nevzati E, Shafighi M, Bakhtian KD. Acta Neurochir Suppl. 2015;120:141-5. Chakrabarti S, Lekontseva O, Davidge S. IUBMB Life. June 2008; 606(6): 376-382

slide-9
SLIDE 9

The Impact of Menopause: Vasodilation

  • Typically expressed as systolic hypertension.
  • Largely develops around the time of menopause -- Attributed to the decline

in estrogen

  • Risk factor for CAD and other cardiometabolic events

Lee V and Foody J. Current Atheroscleorosis Reports. 2008; 10:295-302.

85% of all women in the US are hypertensive by the age of 75.

slide-10
SLIDE 10

Menopause: Antioxidant Activity

  • Estrogen maintains superoxide dismutase

(SOD) expression in vascular tissue

  • Estrogens are direct antioxidants
  • The Impact of Menopause: The loss of

estrogen results in a decline in these protective benefits

Chakrabarti S, Lekontseva O, Davidge S. IUBMB Life. June 2008; 606(6): 376-382

slide-11
SLIDE 11

Menopause: Lipid Metabolism

Cholesterol Levels after Menopause:

  • LDL levels rise (generally exceeding those of men) as well as oxidized LDL
  • HDL levels decline

Triglyceride levels after Menopause:

  • Male triglyceride levels typically decline after mid age
  • Female triglyceride levels tend to increase until the age of 70

Saltiki, K and Alevizaki M. Hormones. 2007; 6(1): 9-24

In the Framingham Study, every 10 mg/dL increase in HDL-C reduced the risk of CAD by 40-50% in women

Mahmood S, Levy D, Vasan R, et al. Lancet. 2014 Mar 15; 383(9921): 999–1008.

slide-12
SLIDE 12

Lead exposure is associated with cardiovascular risk

The Impact of Menopause

  • Loss of bone density
  • 90% of lead accumulates in bone
  • Lead stored in bone is released into circulation

Women in their second year of amenorrhea had blood lead levels 50% higher than pre- and peri-menopausal women

Vahter M, Berglund M, Åkesson A. J Br Menopause Soc. 2004 Jun;10(2):60-4.

slide-13
SLIDE 13

Circadian Rhythms

~24 hour oscillations in physiology and metabolism that allow organisms to predict the availability of food and light.

slide-14
SLIDE 14

Circadian rhythms: Clinical relevance

  • The suprachiasmatic nucleus (SCN)

detects light

  • “Peripheral clocks” respond to it, and

also respond to meal timing

  • The peripheral clocks regulate insulin

response, lipid metabolism, appetite, microbiome, cortisol, blood pressure, many other processes

Brain clocks Bone clocks Vascular clocks Liver clocks Gut clocks Ovarian clocks

slide-15
SLIDE 15

Menopause Overview

A decline in estrogen, as in menopause, is associated with changes in:

  • 1. Vascular health
  • 2. Lipid metabolism
  • 3. Levels of oxidative stress
  • 4. Circadian rhythm

Earlier menopause à Increased risk of cardiovascular complications

Chakrabarti S, Lekontseva O, Davidge S. IUBMB Life. June 2008; 606(6): 376-382 Saltiki, K and Alevizaki M. Hormones. 2007; 6(1): 9-24

slide-16
SLIDE 16

Hormone Replacement Therapy

Clinical trials on HRT and cardiovascular health are inconsistent. The WHI used conjugated estrogens from horse urine and a progestin, since shown to cause harm Few human trials with bio- identical hormone

Saltiki, K and Alevizaki M. Hormones. 2007; 6(1): 9-24

slide-17
SLIDE 17

What can you do?

Non-modifiable Risk Factors

  • Age
  • Gender
  • Race
  • Menopause
  • Family history: Parental history
  • f CAD increases a women’s

risk by 70% Modifiable Risk Factors § Tobacco and drug use § Diet § Sleep and circadian rhythm § Stress management § Cholesterol and lipid metabolism § Physical inactivity § Increased BMI and/or waist circumference § Glucose metabolism

Ramachandran H, Wu V, Kowitlawakul Y and Wang W.. Heart & Lung. 2016; 45: 173-185

slide-18
SLIDE 18

Where to Start?

1. Lab Testing and Imaging 2. Exercise 3. Diet 4. Supplementation*

*These statements have not been evaluated by the Food & Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

slide-19
SLIDE 19

Testing

  • Inflammatory markers
  • Advanced and routine lipids
  • Oxidized LDL
  • Apo E
  • MTHFR
  • ADMA
  • Micronutrients
  • Microalbumin
  • Heavy metals
  • Gut health status

Imaging: Carotid Artery Ultrasound with CIMT, Echocardiogram Lab Studies:

slide-20
SLIDE 20

Asymmetric Dimethylarginine (ADMA)

  • eNOS inhibitor
  • Occurs naturally in plasma
  • Levels are affected by blood lipids,

homocysteine, glucose, thyroid hormones

  • Citrulline supports higher Arginine:ADMA

ratio

NOS ADMA competes and wins Arginine

slide-21
SLIDE 21

Detecting Endothelial Function with ADMA

Nevzati E et al. Estrogen induces nitric oxide production via nitric oxide synthase activation in endothelial cells. Acta Neurochir Suppl. 2015;120:141-5. Chakrabarti S, et al. Estrogen is a modulator of vascular inflammation. IUBMB Life. June 2008; 606(6): 376-382 Ito et al. Novel mechanism for endothelial dysfunction: dysregulation of dimethylarginine dimethylaminohyrolase. Circulation. 1999; 99: 3092-3095.

eNOS

Nitric Oxide

+ L-Citrulline L-Arginine

ADMA

L-Arginine

ADMA

DDAH

L-citrulline + dimethylamine

eNOS

Nitric Oxide + L-Citrulline

DDAH

L-citrulline + dimethylamine

  • xLDL

TNFα

Normal conditions Increased oxLDL, inflammatory cytokines

slide-22
SLIDE 22

Estrogen Rescues NO deficiency

Estrogen can overcome the effects of oxLDL to increase NO production Elevations in ADMA correlate with carotid thickness Hormone therapy (long term >2 years) slows progression of CIMT in healthy post-menopausal women L-Arginine

ADMA eNOS Nitric Oxide

+ L-Citrulline

Estrogen

DDAH

L-citrulline + dimethylamine

  • xLDL

Monsalve et al. Estradiol counteracts oxidized LDL-induced asymmetric dimethylarginine production by cultured human endothelial cells. Cardiovascular

  • Res. 2007; (73): 66-72

Ito et al. Novel mechanism for endothelial dysfunction: dysregulation of dimethylarginine dimethylaminohyrolase. Circulation. 1999; 99: 3092-3095. Maas R. Association of the endogenous nitric oxide synthase inhibitor ADMA with carotid artery intimal media thickness in the Framingham heart study

  • ffspring cohort.

Tostes et al. Effects of estrogen on the vascular system. Braz J Med Biol Res. 2003;36:1143-5

slide-23
SLIDE 23

Exercise

Lack of exercise is as much of a risk factor as smoking! Research has shown that women who regularly exercise have:

  • Lower blood pressure
  • Healthy Blood glucose levels
  • Improved lipid profiles
  • Reduced weight

Lee V and Foody J. Current Atherosclerosis Reports. 2008; 10:295-302.

slide-24
SLIDE 24

Diet

Initially, if any abnormalities, start with a modified vegan diet As health improves, progress to a modified Mediterranean diet

  • Clinical studies have found that a

Mediterranean diet improves lipid levels (raise HDL and lower TG) in postmenopausal women

Bihuniak, J. D., Ramos, A., Huedo-Medina, T. et al.. J Acadam Nutri & Diet. 2016. 116(11), 1767- 1775.

slide-25
SLIDE 25

Diet: Feed Your Microbiome!

  • Complex carbohydrates (70%) whole-grains, all varieties of

vegetables, beans, legumes, etc.

  • Healthy fats (omega’s 3, 6 and 9) from nuts, seeds, olives and

coconut

  • Natural fiber and prebiotic rich foods
  • Probiotic rich foods
  • Green leafy vegetables and root vegetables

INCLUDE

LIMIT AVOID

  • Initially, protein from dairy and eggs
  • Sugar and refined carbohydrates
  • Alcohol
  • Food intolerances
  • Protein (approximately 12%)
slide-26
SLIDE 26

Diet: Meal Timing to support circadian rhythms

slide-27
SLIDE 27

Supplements: Key Areas of Support*

  • 1. Lipid and glucose metabolism
  • 2. Antioxidant status
  • 3. Endothelial function and arterial

wall integrity

  • 4. Blood flow

*These statements have not been evaluated by the Food & Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

slide-28
SLIDE 28

Berberine supports cardiometabolic health*

Over a 3 month period, berberine significantly reduced waist circumference (in women), moderated triglycerides and supported insulin sensitivity.* After 3 months, berberine administration significantly decreased body weight, BMI while supporting healthy lipid profiles compared to placebo.*

Derosa G, D'Angelo A, Bonaventura A, et al. Expert Opin Biol Ther. 2013 Apr;13(4):475-82.

*These statements have not been evaluated by the Food & Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

Pérez-Rubio KG, González-Ortiz M, Martínez-Abundis E. Metab Syndr Relat Disord. 2013 Oct;11(5):366- 9.

slide-29
SLIDE 29

N-acetyl-l-cysteine

Derivative of the amino acid: l-cysteine Precursor to glutathione In animal models, NAC supported:*

  • Healthy lipoprotein function
  • Immune mediator activity in the arterial wall
  • Glucose homeostasis
  • Antioxidant status
  • Glutathione status

Meng XP, Yin CS, Li ZX, et al. Zhonghua yi xue za zhi. 2009; 89(26):1850-1853] Souza GA, Ebaid GX, Seiva FR, et al. Evid Based Complement Alternat Med. 2011;2011:643269.

*These statements have not been evaluated by the Food & Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

slide-30
SLIDE 30

Polyphenols

Micronutrients with antioxidant activity* Key role in insulin sensitivity, cellular health, cognition, and cardiovascular health* Play an important role as a prebiotic, increasing ratio of beneficial bacteria in gut*

  • Pomegranate
  • Resveratrol
  • Quercetin
  • Olives
  • Green tea

*These statements have not been evaluated by the Food & Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

slide-31
SLIDE 31

Phytosterols

1. Compete with cholesterol for absorption into the body* 2. Promote excretion of cholesterol via bile acids* Plant sterol moderated LDL-cholesterol concentrations from baseline by between 15.1% and 26.8%.* Meta-analyses of over 40 clinical trials suggest that phytosterols provide significant support for healthy lipid profiles.*

Chen JT, Wesley R, Shamburek RD, et al. Pharmacotherapy. 2005 Feb;25(2):171-83.

*These statements have not been evaluated by the Food & Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

Lau VW, Journoud M, Jones PJ. Am J Clin Nutr. 2005 Jun;81(6):1351-8.

slide-32
SLIDE 32

Bergamot Orange Extract

Bergamot - flavonoids that moderate hydroxymethylglutarate (HMG)-CoA reductase, which promotes lipid biosynthesis. In animal models, Bergamot maintained healthy lipid, triglyceride and plasma glucose levels in 30 days*

Mollace V, Sacco I, Janda E, et al. Fitoterapia. 2011 Apr;82(3):309-16. Leopoldini M, Malaj N, Toscano M, et al. J Agric Food Chem. 2010 Oct 13;58(19):10768-73.

*These statements have not been evaluated by the Food & Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

slide-33
SLIDE 33

Supporting Nitric Oxide: Why Citrulline?

Arginase: degrades orally administered L-arginine

  • Restricts arginine absorption by 38% - 70%

Citrulline not degraded by arginase

Schwedhelm et al. Br J Clin Pharmacol. 2008 January; 65(1): 51–59.

*These statements have not been evaluated by the Food & Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

L-citrulline increased AUC and Cmax of plasma L-arginine more effectively than L- arginine*

slide-34
SLIDE 34

Citrulline

  • Better absorbed
  • Up to 80% of the ingested dose

used to make NO

  • Augments plasma arginine
  • L-citrulline increased L-

arginine/ADMA ratio, urinary nitrate and cGMP

Wijnands et al. PLoS One (2012)

NO

ARGININE CITRULLINE NOS

slide-35
SLIDE 35

Additional Options

Key Ingredients Details

  • Berberine
  • Resveratrol

Supports healthy insulin function and glucose homeostasis*

  • EPA & DHA rich fish oils

Supports healthy TGs and lipid metabolism, maintains healthy blood flow, and supports healthy platelet function*

  • GABA
  • Valerian root extract

Promotes the onset of sleep as well as sleep quality*

  • Lignans

Moderates occasional hot flashes and supports menopausal health, comfort and emotional well- being*

  • L. acidophilus
  • B. lactis

A dairy-free blend of key probiotic bacteria to support immune and gastrointestinal health*

*These statements have not been evaluated by the Food & Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

slide-36
SLIDE 36

Summary

*These statements have not been evaluated by the Food & Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

*

slide-37
SLIDE 37

Thank you for your kind attention!

Felice L. Gersh, MD fgersh@integrativemgi.com 949-753-7475

37